Cardinal Health, Inc.

Cardinal Health, Inc.(CAH)股票分析

$247.740

+8.299 (+3.35%)收盤時

Loading chart…
最高
247.930
開盤
240.900
成交量加權均價
245.48
成交量
1.97M
市值
24.26B
最低
240.760
成交金額
484.31M
企業價值/稅息折舊攤銷前利潤(TTM)
12.88

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

AI 分析 of Cardinal Health, Inc. (CAH)

買進

Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.

分析師評級(16)

-9.11% 下跌空間
持有
1 買進
15 持有
0 賣出
目前: 247.74
最低
209.00
平均
225.18
最高
244.00

RBC Capital

2026-08-19

目標價

$276

優於大盤

TD Cowen

2026-08-13

目標價

$280

買進

JPMorgan

2026-08-13

目標價

$260

中性

Barclays

2026-08-13

目標價

$275

增持

Morgan Stanley

2026-08-12

目標價

$265

增持

估值指標

Cardinal Health, Inc.(CAH)目前預期本益比為 17.70,5 年平均預期本益比為 14.28。

預期本益比

高估
5 年均值 P/E
14.28
目前P/E
17.70
高估
17.21
低估
11.36

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
9.71
目前EV/EBITDA
12.88
高估
11.94
低估
7.49

預期股價營收比

嚴重高估
5 年均值 P/S
0.12
目前P/S
0.20
高估
0.16
低估
0.09

Alphio AI 對 CAH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CAH

$146.16

情境價格

基

基準

基準 · 50%CAH

$128.79

情境價格

悲

悲觀

悲觀 · 25%CAH

$107.97

情境價格

持有 CAH 的大戶

M

Martingale Asset Management, L.P.

+ 持有CAH

+7.91%

3個月報酬率

O

Osmosis Investment Management UK Limited

+ 持有CAH

+7.38%

3個月報酬率

O

Osaic Advisory Services, LLC

+ 持有CAH

+7.33%

3個月報酬率

N

Numeric Investors LLC

+ 持有CAH

+7.32%

3個月報酬率

V

Voleon Capital Management LP

+ 持有CAH

+7.07%

3個月報酬率

K

Kepler Cheuvreux SA

+ 持有CAH

+6.63%

3個月報酬率

事件時間軸

2026-10-01 (ET)

16:30:00

Major Averages Little Changed as Micron Reports Strong Q4 Earnings

12:00:00

Major Averages Decline as Treasury Yields Rise

07:00:00

Cardinal Health Reaffirms FY 2027 EPS Guidance

07:00:00

Cardinal Health Extends Agreement with CVS Health to June 30, 2032

2026-08-12 (ET)

08:30:00

Keurig Dr Pepper Appoints Aaron Alt as Director

資訊

CAH 常見問題 —— 由 Alphio AI 解答

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

Cardinal Health Inc is a good buy right now due to its strong recent performance and positive growth outlook. The current price is $237.57, and analysts have set price targets as high as $280, indicating potential upside of over 17%. Additionally, the company has shown a year-to-date change of +15.48% and a one-year change of +53.96%, reflecting robust growth. However, the main risk is its current ratio of 0.88, indicating potential liquidity concerns.

16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易